BioTek will likely outgrow the building in about seven years — at which time the company will expand again, Alpert said. He has done the math.

BioTek Instruments announced its sale for $1.165 billion to a California company Thursday, joining a rare club of Vermont companies to command 10-figure prices. "It's been a great day and a busy ...

Agilent began building that portfolio in 2015, when it shelled out $235 million cash to acquire Seahorse Bioscience, ... Privately-held BioTek generated 2018 revenues of $162 million, ...